Correction: Partial Amendment of the Consolidated Financial Results Summary for the Fiscal Year Ending March 2026 (Japanese GAAP)

Summary of Results

MT Genex posted consolidated net sales of ¥4,714 million (up 19.3% YoY), operating income of ¥463.9 million (up 12.9% YoY), ordinary income of ¥489.9 million (up 13.4% YoY), and net income attributable to owners of the parent of ¥314.9 million (up 18.8% YoY) for the fiscal year ending March 2026. The Renewal business led growth within segments, with Renewals driving notable increases in sales and profit. Cash flow from operating activities increased by ¥76.3 million, investing activities were △¥28.8 million, and financing activities were △¥60.9 million. Revised figures have been disclosed, maintaining a stable financial foundation.

Future Outlook and Capital Allocation

For the next term, the company expects net sales of ¥6,100 million (up 29.4% YoY), operating income of ¥686 million (up 47.9% YoY), ordinary income of ¥700 million (up 42.9% YoY), and net income attributable to owners of the parent of ¥426 million (up 35.3% YoY). Dividends are planned to be maintained at ¥40 per share. The company plans active recruitment and M&A to expand business domains and strengthen human resources and to attract group-external customers. Although market conditions remain uncertain, demand in the office-related businesses is expected to stay stable.